A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Clinical trial NCT06329141 · COMPLETED

Trial details

NCT number: NCT06329141
Sponsor: Glaceum
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2024-07-22
Primary completion: 2025-12-16
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.